CompletedPhase 4NCT04050540

Doxycycline PEP for Prevention of Sexually Transmitted Infections Among Kenyan Women Using HIV PrEP

Studying Acquired immunodeficiency

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Washington
Principal Investigator
Jared Baeten, MD, PhD
University of Washington
Intervention
Doxycycline(drug)
Enrollment
449 enrolled
Eligibility
18-30 years · FEMALE
Timeline
20202022

Study locations (1)

Collaborators

Kenya Medical Research Institute · Kenya National AIDS & STI Control Programme · University of California, San Francisco · National Institute of Allergy and Infectious Diseases (NIAID)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04050540 on ClinicalTrials.gov

Other trials for Acquired immunodeficiency

Additional recruiting or active studies for the same condition.

See all trials for Acquired immunodeficiency

← Back to all trials